Ju In Eom
Overview
Explore the profile of Ju In Eom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
249
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheong J, Kim Y, Eom J, Jeung H, Min Y
Mol Med Rep
. 2016 Mar;
13(4):3433-40.
PMID: 26935591
Autophagy is a lysosomal degradation mechanism that is essential for cell survival, differentiation, development, and homeostasis. Autophagy protects cells from various stresses, including protecting normal cells from harmful metabolic conditions,...
2.
Cheong J, Min Y, Eom J, Kim S, Jeung H, Kim J
Anticancer Res
. 2010 Dec;
30(11):4625-34.
PMID: 21115916
Background/aim: The CD34(+)CD38(-) leukaemia cell population contains leukaemia stem cells (LSCs) responsible for treatment failure in acute myeloid leukaemia (AML) and, thus, novel therapies are required to eradicate LSCs without...
3.
Kim Y, Eom J, Kim S, Jeung H, Cheong J, Kim J, et al.
J Pharmacol Exp Ther
. 2010 Aug;
335(2):389-400.
PMID: 20699435
Given that parthenolide (PTL) is an effective antileukemic agent, identifying molecular markers that predict response to PTL is important. We evaluated the role of myeloperoxidase (MPO) in determining the sensitivity...
4.
Cheong J, Jung H, Eom J, Kim S, Jeung H, Min Y
Cancer Lett
. 2010 Jun;
297(2):171-81.
PMID: 20547440
Aurora-A (Aur-A) is a centrosome-associated serine/threonine kinase that is overexpressed in various cancers and potentially correlated with chemoresistance. In the Ara-C-sensitive leukemia cell lines, silencing of Aur-A by small interfering...
5.
Kim J, Eom J, Cheong J, Choi A, Lee J, Yang W, et al.
Clin Cancer Res
. 2007 Feb;
13(3):1019-28.
PMID: 17289898
Introduction: Protein kinase CK2 is implicated in cellular proliferation and transformation. However, the clinical and biological significances of CK2 have not been elucidated in acute myeloid leukemia (AML). Experimental Design:...
6.
Min Y, Cheong J, Kim J, Eom J, Lee S, Hahn J, et al.
Cancer Res
. 2004 Aug;
64(15):5225-31.
PMID: 15289327
Cyclin-dependent kinase inhibitor p27Kip1 functions at the nuclear level by binding to cyclin E/cyclin-dependent kinase-2. It was shown that Akt or protein kinase B (Akt/PKB)-dependent phosphorylation of p27Kip1 led to...
7.
Cheong J, Chong S, Kim J, Eom J, Jeung H, Maeng H, et al.
Clin Cancer Res
. 2003 Oct;
9(13):5018-27.
PMID: 14581377
Purpose: Apicidin, a histone deacetylase inhibitor, is a novel cyclic tetrapeptide that exhibits potent antiproliferative activity against various cancer cell lines. The aim of this study was to examine the...
8.
Cheong J, Eom J, Maeng H, Lee S, Hahn J, Ko Y, et al.
Leuk Res
. 2003 Aug;
27(12):1159-62.
PMID: 12921955
The transcription factor FKHR, which is controlled by Akt-PKB signaling, is involved in regulating cell cycle progression and cell death. In this study, the phosphorylation of FKHR was observed in...
9.
Cheong J, Eom J, Maeng H, Lee S, Hahn J, Ko Y, et al.
Br J Haematol
. 2003 Jul;
122(3):454-6.
PMID: 12877673
Phosphorylation of PTEN (phosphatase and tensin homologue) affects PTEN protein stability and function. In this study, phosphorylated PTEN (pPTEN) was observed in 45 (73.8%) of 61 cases with acute myeloid...